NMS Labs Announces Promotion of Gregory Schuh as Chief Financial Officer
NMS Labs, a national leader in forensic and clinical toxicology services, is pleased to announce the promotion of Gregory Schuh to Chief Financial Officer, effective July 21, 2026. His promotion reflects NMS Labs’ continued investment in operational excellence, financial stewardship, and commercial growth.
NMS Labs Announces Appointment of Tatyana Kosheleva as Chief Financial Officer Amid Executive Team Expansion
NMS Labs, a national leader in forensic and clinical toxicology services, is pleased to announce the appointment of Tatyana Kosheleva as Chief Financial Officer, effective April 28, 2025. Her appointment is part of a broader evolution of the company’s leadership team, reflecting NMS Labs’ continued investment in operational excellence, financial stewardship, and commercial growth.
NMS Labs Selects David Delia as New CEO
NMS Labs announced today that David Delia has been selected as the new President and Chief Executive Officer of the Company. Mr. Delia will guide the organization’s growth while upholding our dedication to quality and service.
